Investigational Drug Information for Clemizole
✉ Email this page to a colleague
What is the drug development status for Clemizole?
Clemizole is an investigational drug.
There have been 4 clinical trials for Clemizole.
The most recent clinical trial was a Phase 1 trial, which was initiated on September 15th 2020.
The most common disease conditions in clinical trials are Syndrome, Epilepsies, Myoclonic, and Hepatitis A. The leading clinical trial sponsors are Epygenix, Eiger BioPharmaceuticals, and GreenLight Clinical PTY LTD.
There are three hundred and forty US patents protecting this investigational drug and three international patents.
Summary for Clemizole
| US Patents | 340 |
| International Patents | 3,871 |
| US Patent Applications | 1,380 |
| WIPO Patent Applications | 712 |
| Japanese Patent Applications | 235 |
| Clinical Trial Progress | Phase 1 (2020-09-15) |
| Vendors | 69 |
Recent Clinical Trials for Clemizole
| Title | Sponsor | Phase |
|---|---|---|
| EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in Children With Lennox Gastaut Syndrome. | Epygenix | Phase 2 |
| EPX-100 (Clemizole Hydrochloride) as Add-on Therapy to Control Convulsive Seizures in Patients With Dravet Syndrome | GreenLight Clinical PTY LTD | Phase 2 |
| EPX-100 (Clemizole Hydrochloride) as Add-on Therapy to Control Convulsive Seizures in Patients With Dravet Syndrome | Epygenix | Phase 2 |
Clinical Trial Summary for Clemizole
Top disease conditions for Clemizole
Top clinical trial sponsors for Clemizole
US Patents for Clemizole
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Clemizole | ⤷ Try a Trial | Heterocyclic compound | Takeda Pharmaceutical Company Limited (Osaka, JP) | ⤷ Try a Trial |
| Clemizole | ⤷ Try a Trial | .beta.-D-2'-deoxy-2'-.alpha.-fluoro-2'-.beta.-C-substituted-2-modified-N.s- up.6-substituted purine nucleotides for HCV treatment | Atea Pharmaceuticals, Inc. (Boston, MA) | ⤷ Try a Trial |
| Clemizole | ⤷ Try a Trial | Methods and compositions for treating infection | UNIVERSITY OF ROCHESTER (Rochester, NY) UNIVERSITY OF KANSAS (Lawrence, KS) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Clemizole
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Clemizole | Canada | CA2961033 | 2034-09-11 | ⤷ Try a Trial |
| Clemizole | European Patent Office | EP3192791 | 2034-09-11 | ⤷ Try a Trial |
| Clemizole | Japan | JPWO2016039408 | 2034-09-11 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
